Theodore Samuels - Perrigo Company Independent Director

PRGO -- USA Stock  

Last Earning Anouncement Date: December 31, 2015  

  Director
Mr. Theodore R. Samuels is an Independent Director of the Company. From 1981 to 2017, Mr. Samuels was an investor at Capital Group, a financial services company, and he served as President of Capital Guardian Trust Company, an affiliated company of Capital Group, from 2010 to 2016. While at Capital Group, he also served on The Capital Group board, audit committee and finance committee, as well as on numerous management and investment committees. Mr. Samuels was a director for Stamps.com since January 2017 and a director of BristolMyers Squibb since February 2017.
Age: 63  Director Since 2017      
353 1 709 4000  http://www.perrigo.com

Theodore Samuels Latest Insider Activity

Theodore Samuels over two months ago via Macroaxis 
Perrigo Company exotic insider transaction detected

Management Efficiency

The company has return on total asset (ROA) of 2.34 % which means that it generated profit of $2.34 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of 1.49 % meaning that it created $1.49 on every $100 dollars invested by stockholders.
The company currently holds 3.62 B in liabilities with Debt to Equity (D/E) ratio of 63.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Perrigo Company has Current Ratio of 1.88 which is within standard range for the sector.

Similar Executives

Showing few of many executives

DIRECTOR Since

Charles BakerRegeneron Pharmaceuticals
N/A
Bonnie BasslerRegeneron Pharmaceuticals
2016
David GreenwayVertex Pharmaceuticals Incorpor
2017
Yuchun LeeVertex Pharmaceuticals Incorpor
2012
Allan ObermanDr Reddys Laboratories Ltd
2019
Marc TessierLavigneRegeneron Pharmaceuticals
2011
Willie ReedZoetis
2014
Paul BisaroZoetis
2015
Michael BrownRegeneron Pharmaceuticals
1991
Margaret McGlynnVertex Pharmaceuticals Incorpor
2011
Michael TrimbleOrigin Agritech Limited
2006
Bruce CarterDr Reddys Laboratories Ltd
2008
William YoungVertex Pharmaceuticals Incorpor
2014
Sanjay KhoslaZoetis
2013
Geoffery MerszeiOrigin Agritech Limited
2016
Yingqi XiaOrigin Agritech Limited
2010
Hans HaslerDr Reddys Laboratories Ltd
2016
Fei WangOrigin Agritech Limited
2019
Sridar IyengarDr Reddys Laboratories Ltd
2011
Linda RhodesZoetis
2017
William DoyleZoetis
2015

Entity Summary

Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland. Perrigo Company operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10600 people.Perrigo Company Plc (PRGO) is traded on BATS Exchange in USA and employs 10,600 people.

Perrigo Company Leadership Team

John Hendrickson, President
Gary Cohen, Independent Director
Arthur Shannon, IR Contact Officer
Ronald Winowiecki, Acting CFO
Svend Andersen, Executive Vice President and President - Consumer Healthcare International
Judy Brown, CFO and Executive VP
Laurie Brlas, Independent Director
Donal OConnor, Independent Director
James Michaud, Chief Human Resource Officer, Executive Vice President
Louis Yu, Executive Vice President - Global Quality
John Wesolowski, Executive Vice President and Presidentident - RX
Theodore Samuelsto, Independent Director
Scott Jamison, Executive Vice President General Manager - Nutritionals
Ellen Hoffing, Independent Director
Marc Coucke, Executive Vice President General Manager - Omega Pharma Business
Adriana Karaboutis, Independent Director
Michael Jandernoa, Independent Director
Paul Weninger, Executive Vice President - Global Quality Operations
Thomas Farrington, Senior Vice President CIO
Herman Morris, Independent Director
Jeffrey Needham, Executive Vice President General Manager - Consumer Healthcare
Todd Kingma, Executive VP, General Counsel and Secretary
Rolf Classon, Independent Director
Raymond Silcock, CFO
Shlomo Yanai, Independent Director Nominee
Jatin Shah, Senior Vice President Chief Scientific Officer
Michael Stewart, Senior Vice President - Global Human Resources
Jeffrey Kindler, Independent Director
Jacqualyn Fouse, Independent Director
Grainne Quinn, Executive Vice President Chief Medical Officer
Theodore Samuels, Independent Director
Geoffrey Parker, Independent Director
Murray Kessler, President CEO, Director
Sharon Kochan, Executive VP and General Manager of International
Gary Kunkle, Lead Independent Director
Joseph Papa, Chairman and CEO
Marry Brlas, Independent Chairman of the Board
Bradley Alford, Independent Director
Jeffrey Smith, Independent Director
Bradley Joseph, IR Contact Officer
James Dillard, Executive Vice President Chief Scientific Officer
Douglas Boothe, Executive Vice President General Manager - Rx Pharmaceuticals
Ronald Janish, Executive Vice President - Global Operations and Supply Chain
Uwe Rohrhoff, President CEO, Director

Stock Performance Indicators

Did you try this?

Run Watchlist Optimization Now

   

Watchlist Optimization

Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
All  Next Launch Module

Currently Active Assets on Macroaxis

DOX   
Purchased few shares of
few hours ago
Traded for 66.25
LN   
Purchased over 30 shares of
few hours ago
Traded for 36.33
SPNS   
Purchased over 100 shares of
few hours ago
Traded for 19.74
CBLK   
Purchased over 50 shares of
few hours ago
Traded for 26.0
TSEM   
Purchased few shares of
few hours ago
Traded for 21.83
Additionally take a look at Your Equity Center. Please also try Premium Stories module to follow macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Search macroaxis.com